15th January 2021 Missed our free GatewayC webinar on Diagnosing Ovarian Cancer? Watch our recording here. In this webinar, GatewayC met Professor Gordon Jayson, Professor of Medical Oncology at The Christie NHS Foundation Trust, who answered key questions from our...
Cancer Keys: Cancer and Dyspepsia
Latest from the Blog
Tuesday 5th January 2021 We are delighted to announce that the new Managing Physical Effects course is now available on GatewayC. According to Macmillan, at least 1 in 4 patients will experience consequences of their cancer or treatment that affect their quality of...
Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...
Potential pitfall: In the early course of the disease, pancreatic cancer may not cause any signs or symptoms. However, sudden onset diabetes in groups of patients for whom this would be unexpected can be an early indicator. Helpful hint: NICE NG12 guidelines recommend...
Whilst dyspepsia is commonplace in general practice, it can sometimes be an indicator of stomach or oesophageal cancers.
Typically, dyspepsia may be associated with common and less serious triggers such as lifestyle factors or stress. With patients frequently presenting with dyspepsia, NICE gives clear guidance on which associated symptoms should also be considered that may in turn prompt the need for further investigation.
NICE NG12 guidelines advise to consider direct upper gastrointestinal endoscopy for patients that are over 55, either with treatment-resistant dyspepsia, or present with dyspepsia in addition to:
- Weight loss
- Raised platelet count
- Nausea or vomiting
Cancer Keys are brought to you by GatewayC.
Download this Cancer Key here.
Access GatewayC’s course on early diagnosis of stomach cancer here.